{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:25:03Z","timestamp":1791314703206,"version":"4.3.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","progcardvascdis.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.pcad.2015.05.004","type":"journal-article","created":{"date-parts":[[2015,5,9]],"date-time":"2015-05-09T22:03:07Z","timestamp":1431208987000},"page":"32-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["High-Density Lipoprotein Function Measurement in Human Studies: Focus on Cholesterol Efflux Capacity"],"prefix":"10.1016","volume":"58","author":[{"given":"Anand","family":"Rohatgi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcad.2015.05.004_bb0005","article-title":"2013 ACC\/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","author":"Stone","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2015.05.004_bb0010","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/CIRCULATIONAHA.105.567107","article-title":"Increased small low-density lipoprotein particle number: a prominent feature of the metabolic syndrome in the Framingham Heart Study","volume":"113","author":"Kathiresan","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2015.05.004_bb0015","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1161\/ATVBAHA.109.201020","article-title":"Genetic Variants Influencing Circulating Lipid Levels and Risk of Coronary Artery Disease","volume":"30","author":"Waterworth","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pcad.2015.05.004_bb0020","first-page":"1042","article-title":"Loss-of-function variants in endothelial lipase are a cause of elevated HDL cholesterol in humans","volume":"119","author":"Edmondson","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pcad.2015.05.004_bb0025","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa1300955","article-title":"Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients","volume":"371","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2015.05.004_bb0030","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJMoa064278","article-title":"HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events","volume":"357","author":"Barter","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2015.05.004_bb0035","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1107579","article-title":"Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy","volume":"365","author":"Boden","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2015.05.004_bb0040","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa1206797","article-title":"Effects of dalcetrapib in patients with a recent acute coronary syndrome","volume":"367","author":"Schwartz","year":"2012","journal-title":"N Engl J Med"},{"issue":"50 Suppl.","key":"10.1016\/j.pcad.2015.05.004_bb0045","doi-asserted-by":"crossref","first-page":"S189","DOI":"10.1194\/jlr.R800088-JLR200","article-title":"The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis","author":"Rader","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.pcad.2015.05.004_bb0050","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1194\/jlr.R039479","article-title":"Regulation of signal transduction by HDL","volume":"54","author":"Mineo","year":"2013","journal-title":"J Lipid Res"},{"key":"10.1016\/j.pcad.2015.05.004_bb0055","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0140-6736(14)61217-4","article-title":"HDL and cardiovascular disease","volume":"384","author":"Rader","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2015.05.004_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9150(01)00713-4","article-title":"Cellular cholesterol flux studies: methodological considerations","volume":"163","author":"Rothblat","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pcad.2015.05.004_bb0065","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1161\/ATVBAHA.113.301373","article-title":"Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks","volume":"33","author":"Li","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pcad.2015.05.004_bb0070","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.1073\/pnas.78.6.3911","article-title":"Evidence for a lipoprotein carrier in human plasma catalyzing sterol efflux from cultured fibroblasts and its relationship to lecithin:cholesterol acyltransferase","volume":"78","author":"Fielding","year":"1981","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pcad.2015.05.004_bb0075","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1007\/s00125-012-2570-9","article-title":"Advanced glycation end-products (AGEs) and functionality of reverse cholesterol transport in patients with type 2 diabetes and in mouse models","volume":"55","author":"Low","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.pcad.2015.05.004_bb0080","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0021-9150(96)05962-X","article-title":"Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulin-dependent diabetes: importance of LpA-I:A-II particles and phospholipid transfer protein","volume":"127","author":"Syv\u00e4nne","year":"1996","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pcad.2015.05.004_bb0085","doi-asserted-by":"crossref","DOI":"10.1186\/1476-511X-8-14","article-title":"Macrophage cholesterol efflux correlates with lipoprotein subclass distribution and risk of obstructive coronary artery disease in patients undergoing coronary angiography","volume":"8","author":"Linsel-Nitschke","year":"2009","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.pcad.2015.05.004_bb0090","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa1001689","article-title":"Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis","volume":"364","author":"Khera","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2015.05.004_bb0095","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1056\/NEJMc1101853","article-title":"Cholesterol Efflux Capacity and Atherosclerosis","volume":"364","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2015.05.004_bb0100","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1161\/ATVBAHA.113.301519","article-title":"Cholesterol efflux capacity: full steam ahead or a bump in the road?","volume":"33","author":"Khera","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pcad.2015.05.004_bb1105","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1056\/NEJMoa1409065","article-title":"HDL cholesterol efflux capacity and incident cardiovascular events","volume":"371","author":"Rohatgi","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2015.05.004_bb0110","doi-asserted-by":"crossref","unstructured":"Saleheen D, Scott R, Javad S, et al. Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study. Lancet Diabetes Endocrinol. 2015 May 26. pii: S2213-8587(15)00126-6.doi: 10.1016\/S2213-8587(15)00126-6. [Epub ahead of print]","DOI":"10.1016\/S2213-8587(15)00126-6"},{"key":"10.1016\/j.pcad.2015.05.004_bb0115","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.jacc.2012.09.013","article-title":"Dysfunctional high-density lipoprotein in patients on chronic hemodialysis","volume":"60","author":"Yamamoto","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2015.05.004_bb0120","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.metabol.2014.10.020","article-title":"Dysfunctional high-density lipoproteins in children with chronic kidney disease","volume":"64","author":"Kaseda","year":"2015","journal-title":"Metabolism"},{"key":"10.1016\/j.pcad.2015.05.004_bb0125","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1681\/ASN.2013111212","article-title":"HDL in Children with CKD Promotes Endothelial Dysfunction and an Abnormal Vascular Phenotype","volume":"25","author":"Shroff","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pcad.2015.05.004_bb1130","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1530\/EJE-07-0451","article-title":"Fibroblast cholesterol efflux to plasma from metabolic syndrome subjects is not defective despite low high-density lipoprotein cholesterol","volume":"158","author":"Dullaart","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.pcad.2015.05.004_bb0180","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.atherosclerosis.2012.03.037","article-title":"Pancreatic \u03b2-cell function relates positively to HDL functionality in well-controlled Type 2 diabetes mellitus","volume":"222","author":"Dullaart","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pcad.2015.05.004_bb0140","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.atherosclerosis.2006.12.027","article-title":"Increased cholesterol efflux from cultured fibroblasts to plasma from hypertriglyceridemic type 2 diabetic patients: roles of pre beta-HDL, phospholipid transfer protein and cholesterol esterification","volume":"196","author":"de Vries","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pcad.2015.05.004_bb0225","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.metabol.2014.03.001","article-title":"Enhanced cholesterol efflux to HDL through the ABCA1 transporter in hypertriglyceridemia of type 2 diabetes","volume":"63","author":"Yassine","year":"2014","journal-title":"Metab Clin Exp"},{"key":"10.1016\/j.pcad.2015.05.004_bb0230","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ijo.2011.170","article-title":"Cholesterol efflux from macrophages is influenced differentially by plasmas from overweight insulin-sensitive and -resistant subjects","volume":"36","author":"Nestel","year":"2012","journal-title":"Int J Obes"},{"key":"10.1016\/j.pcad.2015.05.004_bb0155","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/dmrr.895","article-title":"Cellular cholesterol efflux to serum is impaired in diabetic nephropathy","volume":"24","author":"Zhou","year":"2008","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.pcad.2015.05.004_bb0130","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.5551\/jat.24315","article-title":"Relationship between Serum Cholesterol Efflux Capacity and Glucose Intolerance in Japanese-Americans","volume":"21","author":"Kubota","year":"2014","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.pcad.2015.05.004_bb0145","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.atherosclerosis.2012.06.068","article-title":"Abnormal lipoprotein particles and cholesterol efflux capacity in patients with psoriasis","volume":"224","author":"Mehta","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pcad.2015.05.004_bb0170","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1194\/jlr.M027367","article-title":"Psoriasis alters HDL composition and cholesterol efflux capacity","volume":"53","author":"Holzer","year":"2012","journal-title":"J Lipid Res"},{"key":"10.1016\/j.pcad.2015.05.004_bb0175","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1136\/annrheumdis-2011-200493","article-title":"Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis","volume":"71","author":"Charles-Schoeman","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.pcad.2015.05.004_bb0235","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1136\/annrheumdis-2012-202914","article-title":"Impaired serum cholesterol efflux capacity in rheumatoid arthritis and systemic lupus erythematosus","volume":"73","author":"Ronda","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.pcad.2015.05.004_bb0135","doi-asserted-by":"crossref","DOI":"10.1161\/ATVBAHA.114.303374","article-title":"Olive Oil Polyphenols Enhance High-Density Lipoprotein Function in Humans A Randomized Controlled Trial","author":"Hern\u00e1ez","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pcad.2015.05.004_bb0160","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1194\/jlr.M400109-JLR200","article-title":"Moderate alcohol consumption increases cholesterol efflux mediated by ABCA1","volume":"45","author":"Beulens","year":"2004","journal-title":"J Lipid Res"},{"key":"10.1016\/j.pcad.2015.05.004_bb0195","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/ajcn\/86.5.1270","article-title":"Macrophage cholesterol efflux elicited by human total plasma and by HDL subfractions is not affected by different types of dietary fatty acids","volume":"86","author":"Buonacorso","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.pcad.2015.05.004_bb0255","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1194\/jlr.M800271-JLR200","article-title":"Replacement of dietary saturated FAs by PUFAs in diet and reverse cholesterol transport","volume":"49","author":"Kralova Lesna","year":"2008","journal-title":"J Lipid Res"},{"key":"10.1016\/j.pcad.2015.05.004_bb0190","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1249\/MSS.0b013e3181632d2d","article-title":"HDL Atheroprotection by Aerobic Exercise Training in Type 2 Diabetes Mellitus","volume":"40","author":"Ribeiro","year":"2008","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.pcad.2015.05.004_bb0495","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ahj.2013.05.021","article-title":"Exercise-mediated changes in high-density lipoprotein: Impact on form and function","volume":"166","author":"Blazek","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.pcad.2015.05.004_bb0200","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1038\/oby.2012.56","article-title":"Diet-induced weight loss in overweight or obese women and changes in high-density lipoprotein levels and function","volume":"20","author":"Aicher","year":"2012","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.pcad.2015.05.004_bb0240","doi-asserted-by":"crossref","first-page":"E841","DOI":"10.1210\/jc.2013-3918","article-title":"Decreased cholesterol efflux capacity and atherogenic lipid profile in young women with PCOS","volume":"99","author":"Roe","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pcad.2015.05.004_bb1225","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1161\/01.ATV.15.12.2130","article-title":"Abnormal reverse cholesterol transport in controlled type II diabetic patients. Studies on fasting and postprandial LpA-I particles","volume":"15","author":"Cavallero","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pcad.2015.05.004_bb0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0009-8981(98)00155-7","article-title":"Abnormal capacity to induce cholesterol efflux and a new LpA-I pre-beta particle in type 2 diabetic patients","volume":"279","author":"Brites","year":"1999","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.pcad.2015.05.004_bb0205","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1177\/1479164109344934","article-title":"Impaired serum capacity to induce cholesterol efflux is associated with endothelial dysfunction in type 2 diabetes mellitus","volume":"6","author":"Zhou","year":"2009","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.pcad.2015.05.004_bb0210","doi-asserted-by":"crossref","first-page":"407","DOI":"10.33549\/physiolres.931769","article-title":"May Alcohol-Induced Increase of HDL Be Considered as Atheroprotective?","volume":"59","author":"Kr\u00e1lov\u00e1 Lesn\u00e1","year":"2010","journal-title":"Physiol Res"}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003306201500033X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003306201500033X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T19:17:42Z","timestamp":1651951062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003306201500033X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S003306201500033X"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2015.05.004","relation":{},"ISSN":["0033-0620"],"issn-type":[{"value":"0033-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-Density Lipoprotein Function Measurement in Human Studies: Focus on Cholesterol Efflux Capacity","name":"articletitle","label":"Article Title"},{"value":"Progress in Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcad.2015.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}